The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative ...

The Food and Drug Administration said it will be taking steps to speed up the approval process for developing generic biological drugs, an effort aimed at increasing cheaper competition among ...

The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex ...

The FDA said it proposed significant changes to simplify biosimilarity studies and reduce what it described as unnecessary ...

There are three obstacles to faster development and deployment of non-addictive pain treatments. They are the business ...

Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...

With each new year comes a new set of accompanying challenges, from tackling the latest innovations to new incarnations of old issues. 2025 will be no exception to this rule, and with its arrival we ...

Guidance development and publication from the Food and Drug Administration (FDA) has long been considered an essential element of medical product development, approval, and regulation. While temporary ...

The United States has said it will speed up approval for some generic drugs. The development comes weeks after it was ...

WASHINGTON - The Food and Drug Administration announced Wednesday that it plans to streamline the approval process for ...